In the last trading session, 1.2 million Tandem Diabetes Care Inc (NASDAQ:TNDM) shares changed hands as the company’s beta touched 1.33. With the company’s per share price at $34.11 changed hands at -$1.23 or -3.48% during last session, the market valuation stood at $2.23B. TNDM’s last price was a discount, traded about -57.4% off its 52-week high of $53.69. The share price had its 52-week low at $13.82, which suggests the last value was 59.48% up since then. When we look at Tandem Diabetes Care Inc’s average trading volume, we note the 10-day average is 1.37 million shares, with the 3-month average coming to 1.42 million.
Analysts gave the Tandem Diabetes Care Inc (TNDM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.77. If we narrow down to specifics, the data shows that 1 out of 10 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended TNDM as a Hold, 8 felt it is a Buy and 0 rated the stock as Underweight. Tandem Diabetes Care Inc’s EPS for the current quarter is expected to be -0.4.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Tandem Diabetes Care Inc (NASDAQ:TNDM) trade information
Instantly TNDM was in red as seen at the end of in last trading. With action -8.70%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 15.31%, with the 5-day performance at -8.70% in the red. However, in the 30-day time frame, Tandem Diabetes Care Inc (NASDAQ:TNDM) is -23.57% down. Looking at the short shares, we see there were 10.07 million shares sold at short interest cover period of 8.71 days.
The consensus price target for the stock as assigned by Wall Street analysts is 59, meaning bulls need an upside of 42.19% from its current market value. According to analyst projections, TNDM’s forecast low is 36 with 160 as the target high. To hit the forecast high, the stock’s price needs a -369.07% plunge from its current level, while the stock would need to soar -5.54% for it to hit the projected low.
Tandem Diabetes Care Inc (TNDM) estimates and forecasts
Data shows that the Tandem Diabetes Care Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 7.50% over the past 6 months, a -12.10% in annual growth rate that is considerably lower than the industry average of 13.70%. Year-over-year growth is forecast to reach 19.20% up from the last financial year.
Consensus estimates given by 19 financial analysts project the company’s revenue in the current quarter to hit an average of 223.66M. 19 analysts are of the opinion that Tandem Diabetes Care Inc’s revenue for the current quarter will be 251.63M. The company’s revenue for the corresponding quarters a year ago was 192.71M and 196.8M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 16.10%. The estimates for the next quarter sales put growth at 27.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -6.11%. The 2024 estimates are for Tandem Diabetes Care Inc earnings to increase by 49.98%, but the outlook for the next 5-year period is at 38.80% per year.
TNDM Dividends
Tandem Diabetes Care Inc is expected to release its next quarterly earnings report in November.
Tandem Diabetes Care Inc (NASDAQ:TNDM)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.75% of Tandem Diabetes Care Inc shares while 120.09% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 121.01%. There are 120.09% institutions holding the Tandem Diabetes Care Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 17.1137% of the shares, roughly 11.12 million TNDM shares worth $448.14 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 11.3518% or 7.38 million shares worth $297.26 million as of 2024-06-30.
